Riluzole in Autistic Disorder

Aldred S , Moore KM , Fitzgerald M , Waring RH . Plasma amino acid levels in children with autism and their families. J Autism Dev Disord, 33:93–97. 2003.

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th(DSM-IV)Washington, DC: American Psychiatric Press, 1994.

Autism Speaks Announces Results Reported for the Study of Fluoxetine in Autism (SOFIA). First Industry-Sponsored Trial for the Autism Clinical Trials Network (ACTN) 2009. http://www.autismspeaks.org/press/as_announces_sofia_results.php.

Blatt GJ , Fitzgerald CM , Guptill JT , Booker AB , Kemper TL , Bauman ML . Density and distribution of hippocampal neurotransmitter receptors in autism: An autoradiographic study. J Autism Dev Disord, 31:537–543. 2001.

Carlsson ML . Hypothesis: Is infantile autism a hypoglutamatergic disorder? Relevance of glutamate—serotonin interactions for pharmacotherapy. J Neural Transm, 105:525–535. 1998.

Coric V , Taskiran S , Pittenger C , Wasylink S , Mathalon DH , Valentine G , Saksa J , Wu YT , Gueorguieva R , Sanacora G , Malison RT , Krystal JH . Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: An open-label trial. Biol Psychiatry, 58:424–428. 2005.

Dhossche D , Applegate H , Abraham A , Maertens P , Bland L , Bencsath A , Martinez J . Elevated plasma gamma-aminobutyric acid (GABA) levels in autistic youngsters: Stimulus for a GABA hypothesis of autism. Med Sci Monit, 8:PR1–PR6. 2002.

Erickson CA , Weng N , Weiler IJ , Greenough WT , Stigler KA , Wink LK , McDougle CJ . Open-label riluzole in fragile X syndrome. Brain Res, 1380:264–270. 2011.

Fatemi SH , Halt AR , Stary JM , Kanodia R , Schulz SC , Realmuto GR . Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices. Biol Psychiatry, 52:805–810. 2002.

Frizzo ME , Dall'Onder LP , Dalcin KB , Souza DO . Riluzole enhances glutamate uptake in rat astrocyte cultures. Cell Mol Neurobiol, 24:123–128. 2004.

Fumagalli E , Funicello M , Rauen T , Gobbi M , Mennini T . Riluzole enhances the activity of glutamate transporters GLAST, GLT1 and EAAC1. Eur J Pharmacol, 578:171–176. 2008.

Grant P , Lougee L , Hirschtritt M , Swedo SE . An open-label trial of riluzole, a glutamate antagonist, in children with treatment-resistant obsessive-compulsive disorder. J Child Adolesc Psychopharmacol, 17:761–767. 2007.

Grant P , Song JY , Swedo SE . Review of the use of the glutamate antagonist riluzole in psychiatric disorders and a description of recent use in childhood obsessive-compulsive disorder. J Child Adolesc Psychopharmacol, 20:309–315. 2010.

Guy W . ECDEU Assessment Manual for Psychopharmacology. Washington, DC: National Institute of Mantal Health, U.S. Department of Helath, Education and Wellfare, 1976.

Jamain S , Betancur C , Quach H , Philippe A , Fellous M , Giros B , Gillberg C , Leboyer M , Bourgeron T . Linkage and association of the glutamate receptor 6 gene with autism. Mol Psychiatry, 7:302–310. 2002.

Kim JE , Kim DS , Kwak SE , Choi HC , Song HK , Choi SY , Kwon OS , Kim YI , Kang TC . Anti-glutamatergic effect of riluzole: Comparison with valproic acid. Neuroscience, 147:136–145. 2007.

King BH , Hollander E , Sikich L , McCracken JT , Scahill L , Bregman JD , Donnelly CL , Anagnostou E , Dukes K , Sullivan L , Hirtz D , Wagner A , Ritz L , Network SP . Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: Citalopram ineffective in children with autism. Arch Gen Psychiatry, 66:583–590. 2009.

Marcus RN , Owen R , Kamen L , Manos G , McQuade RD , Carson WH , Aman MG . A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. J Am Acad Child Adolesc Psychiatry, 48:1110–1119. 2009.

Mathew SJ , Amiel JM , Coplan JD , Fitterling HA , Sackeim HA , Gorman JM . Open-label trial of riluzole in generalized anxiety disorder. Am J Psychiatry, 162:2379–2381. 2005.

McDougle CJ , Naylor ST , Cohen DJ , Volkmar FR , Heninger GR , Price LH . A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Arch Gen Psychiatry, 53:1001–1008. 1996.

McDougle CJ , Price LH , Volkmar FR , Goodman WK , Ward-O'Brien D , Nielsen J , Bregman J , Cohen DJ . Clomipramine in autism: preliminary evidence of efficacy. J Am Acad Child Adolesc Psychiatry, 31:746–750. 1992.

Moreno-Fuenmayor H , Borjas L , Arrieta A , Valera V , Socorro-Candanoza L . Plasma excitatory amino acids in autism. Invest Clin, 37:113–128. 1996.

Obrenovitch TP . Amyotrophic lateral sclerosis, excitotoxicity and riluzole. Trends Pharmacol Sci, 19:9–11. 1998.

Owen R , Sikich L , Marcus RN , Corey-Lisle P , Manos G , McQuade RD , Carson WH , Findling RL . Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics, 124:1533–1540. 2009.

Philippe A , Martinez M , Guilloud-Bataille M , Gillberg C , Rastam M , Sponheim E , Coleman M , Zappella M , Aschauer H , Van Maldergem L , Penet C , Feingold J , Brice A , Leboyer M . Genome-wide scan for autism susceptibility genes. Paris Autism Research International Sibpair Study. Hum Mol Genet, 8:805–812. 1999.

Pittenger C , Kelmendi B , Wasylink S , Bloch MH , Coric V . Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: A series of 13 cases, with long-term follow-up. J Clin Psychopharmacol, 28:363–367. 2008.

Posey DJ , McDougle CJ . The pharmacotherapy of target symptoms associated with autistic disorder and other pervasive developmental disorders. Harv Rev Psychiatry, 8:45–63. 2000.

Purcell AE , Jeon OH , Zimmerman AW , Blue ME , Pevsner J . Postmortem brain abnormalities of the glutamate neurotransmitter system in autism. Neurology, 57:1618–1628. 2001.

Remington G , Sloman L , Konstantareas M , Parker K , Gow R . Clomipramine versus haloperidol in the treatment of autistic disorder: A double-blind, placebo-controlled, crossover study. J Clin Psychopharmacol, 21:440–444. 2001.

Research Units on Pediatric Psychopharmacology Autism Unit. Risperidone in children with autism and serious behavioral problems. N Engl J Med, 347:314–321. 2002.

Research Units on Pediatric Psychopharmacology Autism_Unit. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Arch Gen Psychiatry, 62:1266–1274. 2005.

Rolf LH , Haarmann FY , Grotemeyer KH , Kehrer H . Serotonin and amino acid content in platelets of autistic children. Acta Psychiatr Scand, 87:312–316. 1993.

Sanacora G , Kendell SF , Levin Y , Simen AA , Fenton LR , Coric V , Krystal JH . Preliminary evidence of riluzole efficacy in antidepressant-treated patients with residual depressive symptoms. Biol Psychiatry, 61:822–825. 2007.

Urbani A , Belluzzi O . Riluzole inhibits the persistent sodium current in mammalian CNS neurons. Eur J Neurosci, 12:3567–3574. 2000.

Veenstra-VanderWeele J . Increase in valproic acid levels during riluzole treatment in an adolescent with autism. J Child Adolesc Psychopharmacol, 20:163–165. 2010.

Wachtel L . P01-124 Riluzole for affective, behavioral disturbance in autism. Eur Psychiatry, 24:S512. 2009.

Zarate CA Jr , Payne JL , Quiroz J , Sporn J , Denicoff KK , Luckenbaugh D , Charney DS , Manji HK . An open-label trial of riluzole in patients with treatment-resistant major depression. Am J Psychiatry, 161:171–174. 2004.

Zarate CA Jr , Quiroz JA , Singh JB , Denicoff KD , De Jesus G , Luckenbaugh DA , Charney DS , Manji HK . An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression. Biol Psychiatry, 57:430–432. 2005.